Factors Associated With More Severe AD in Children
Factors associated with severe atopic dermatitis in later childhood and self-reported triggers are reported.
Factors associated with severe atopic dermatitis in later childhood and self-reported triggers are reported.
Cutaneous and histopathologic manifestations of COVID-19 infection in a pediatric population are described.
The clinic-etiological factors of patients with hand eczema were assessed.
The randomized, double-blind, double-dummy, active-controlled Heads Up study included 692 patients aged 18 to 75 years with moderate to severe atopic dermatitis who are candidates for systemic therapy.
The association of atopic dermatitis and autoimmune disease was investigated.
The causal effect of genetically predicted vitamin D levels on atopic dermatitis risk was investigated.
The 6-month risk for conjunctivitis in patients with atopic dermatitis treated with dupilumab was evaluated.
Investigators evaluated the relationship between atopic dermatitis and frequency of severity markers in patients hospitalized with COVID-19.
The JADE REGIMEN trial was a responder-enriched, placebo-controlled withdrawal study that included a 12-week open-label run-in period.
The minimal important changes of percentage and absolute improvement of EASI and SCORAD scores in adults and children with AD was determined.